Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 3, 2005, Pages 662.e1-662.e11

  Kher, Ajay ^a   Meldrum, Kirstan K ^a   Hile, Karen L ^a   Wang, Meijing ^a,b   Tsai, Ben M ^a   Turrentine, Mark W ^a   Brown, John W ^a   Meldrum, Daniel R ^a,b,c  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; AUTACOID; CASPASE 3; CASPASE 8; CREATININE; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG DETERMINATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL ASSESSMENT; GENERAL CONDITION IMPROVEMENT; HEPARINIZATION; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TUBULE FUNCTION; MALE; NEPHRITIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 24644515934     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.02.035     Document Type: Article

References (30)

1. K.K. Meldrum, A.L. Burnett, X. Meng, R. Misseri, M.B. Shaw, J.P. Gearhart Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis Circ Res. 92 2003 293 299
2. K.K. Meldrum, D.R. Meldrum, K.L. Hile, E.B. Yerkes, A. Ayala, M.P. Cain p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia Am J Physiol Cell Physiol. 281 2001 C563 C570
3. K.K. Donnahoo, B.D. Shames, A.H. Harken, D.R. Meldrum The role of tumor necrosis factor in renal ischemia-reperfusion injury J Urol. 162 1999 196 203
4. K.K. Donnahoo, X. Meng, A. Ayala, M.P. Cain, A.H. Harken, D.R. Meldrum Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion Am J Physiol. 277 1999 R922 R929
5. K.K. Donnahoo, X. Meng, L. Ao, A. Ayala, B.D. Shames, M.P. Cain Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxaemia Immunology. 102 2001 53 58
6. D.R. Meldrum Tumor necrosis factor in the heart Am J Physiol. 274 1998 R577 R595
7. K.K. Meldrum, D.R. Meldrum, X. Meng, L. Ao, A.H. Harken TNF-alpha-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion Am J Physiol Heart Circ Physiol. 282 2002 H540 H546
8. K.K. Meldrum, D.R. Meldrum, S.F. Sezen, J.K. Crone, A.L. Burnett Heat shock prevents simulated ischemia-induced apoptosis in renal tubular cells via a PKC-dependent mechanism Am J Physiol Regul Integr Comp Physiol. 281 2001 R359 R364
9. A. Kher, M. Wang, B.M. Tsai, J.M. Pitcher, E.S. Greenbaum, R.D. Nagy Sex differences in the myocardial inflammatory response to acute injury Shock. 23 2005 1 10
10. R. Soeparwata, A.R. Hartman, U. Frerichmann, G.B. Stefano, H.H. Scheld, T.V. Bilfinger Aprotinin diminishes inflammatory processes Int J Cardiol. 53 Suppl 1996 S55 S63
11. A. Alonso, C.W. Whitten, G.E. Hill Pump prime only aprotinin inhibits cardiopulmonary bypass-induced neutrophil CD11b up-regulation Ann Thorac Surg. 67 1999 392 395
12. G. Asimakopoulos, A. Kohn, D.C. Stefanou, D.O. Haskard, R.C. Landis, K.M. Taylor Leukocyte integrin expression in patients undergoing cardiopulmonary bypass Ann Thorac Surg. 69 2000 1192 1197
13. G. Asimakopoulos, R. Thompson, S. Nourshargh, E.A. Lidington, J.C. Mason, C.P. Ratnatunga An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation J Thorac Cardiovasc Surg. 120 2000 361 369
14. K.U. Kim, O.J. Kwon, D.M. Jue Pro-tumour necrosis factor cleavage enzyme in macrophage membrane/particulate Immunology. 80 1993 134 139
15. G.E. Hill, A. Alonso, J.R. Spurzem, A.H. Stammers, R.A. Robbins Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans J Thorac Cardiovasc Surg. 110 1995 1658 1662
16. D.A. Bull, R.C. Connors, A. Albanil, B.B. Reid, L.A. Neumayer, R. Nelson Aprotinin preserves myocardial biochemical function during cold storage through suppression of tumor necrosis factor J Thorac Cardiovasc Surg. 119 2000 242 250
17. R.P. Diego, P.J. Mihalakakos, T.D. Hexum, G.E. Hill Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass J Cardiothorac Vasc Anesth. 11 1997 29 31
18. G.E. Hill, R.P. Diego, A.H. Stammers, S.M. Huffman, R. Pohorecki Aprotinin enhances the endogenous release of interleukin-10 after cardiac operations Ann Thorac Surg. 65 1998 66 69
19. M.N. D'Ambra, C.W. Akins, E.H. Blackstone, S.L. Bonney, L.H. Cohn, D.M. Cosgrove Aprotinin in primary valve replacement and reconstruction a multicenter, double-blind, placebo-controlled trial J Thorac Cardiovasc Surg. 112 1996 1081 1089
20. D.M. Cosgrove 3rd, B. Heric, B.W. Lytle, P.C. Taylor, R. Novoa, L.A. Golding Aprotinin therapy for reoperative myocardial revascularization a placebo-controlled study Ann Thorac Surg. 54 1992 1031 1038
21. J.H. Lemmer Jr, W. Stanford, S.L. Bonney, E.V. Chomka, R.B. Karp, G.W. Laub Aprotinin for coronary artery bypass grafting effect on postoperative renal function Ann Thorac Surg. 59 1995 132 136
22. A. Sedrakyan, T. Treasure, J.A. Elefteriades Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery a systematic review and meta-analysis of randomized clinical trials J Thorac Cardiovasc Surg. 128 2004 442 448
23. J.H. Lemmer Jr, E.W. Dilling, J.R. Morton, J.B. Rich, F. Robicsek, D.L. Bricker Aprotinin for primary coronary artery bypass grafting a multicenter trial of three dose regimens Ann Thorac Surg. 62 1996 1659 1668
24. P.K. Smith, L.H. Muhlbaier Aprotinin safe and effective only with the full-dose regimen Ann Thorac Surg. 62 1996 1575 1577
25. M. Schumer, M.C. Colombel, I.S. Sawczuk, G. Gobe, J. Connor, K.M. O'Toole Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia Am J Pathol. 140 1992 831 838
26. D. Pruefer, U. Buerke, M. Khalil, M. Dahm, H. Darius, H. Oelert Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart J Thorac Cardiovasc Surg. 124 2002 942 949
27. Z. Ozer, N. Sucu, D. Dusmez, L. Tamer, A.A. Altunkan, M. DIkmengIl The effect of aprotinin on ischemia-reperfusion injury in the rabbit kidney Pharmacol Res. 44 2001 455 460
28. K. Furuichi, T. Wada, Y. Iwata, N. Sakai, K. Yoshimoto, K. Kobayashi Ki Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice Nephrol Dial Transplant. 17 2002 399 407
29. T. Yin, G. Sandhu, C.D. Wolfgang, A. Burrier, R.L. Webb, D.F. Rigel Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney J Biol Chem. 272 1997 19943 19950
30. K.M. Park, A. Chen, J.V. Bonventre Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment J Biol Chem. 276 2001 11870 11876